Literature DB >> 26346160

Atypical PKC phosphorylates microtubule affinity-regulating kinase 4 in vitro.

Farha Naz1, Asimul Islam1, Faizan Ahmad1, Md Imtaiyaz Hassan2.   

Abstract

MAP/Microtubule affinity-regulating kinase 4 (MARK4), a Ser/Thr protein kinases, is related to the Par-1 (partitioning-defective) gene products, and is the human ortholog of Par-1. MARK4 shows its role in the cell polarity at the time of embryonic development. It is mostly located at the basal region of cells, providing apico-basal polarity. Here, we made two variants of human Par-1d (MARK4), kinase domain (MARK4-F2), and kinase domain along with 59 N-terminal residues (MARK4-F1) and saw their ATPase hydrolysis in the presence of each other. We observed that the activity of one variant was increased in the presence of other. We also demonstrated that both variants were phosphorylated by atypical PKC and their activities were increased in the presence of increasing concentration of atypical protein kinase c (aPKC). The phosphorylation was observed at the serine and threonine residues of MARK4. The interaction of MARK2 and MARK3 with aPKC and their negative regulation by aPKC is already known. This study confirms a functional link between aPKC and MARK4, two central determinants of cell polarity, and it suggests that aPKC may regulate all four members of Par-1 through phosphorylating them in polarized cells.

Entities:  

Keywords:  ATP; Atypical protein kinase C; Cell polarity; Microtubule affinity-regulating kinase; Microtubule dynamics; Par-1

Mesh:

Substances:

Year:  2015        PMID: 26346160     DOI: 10.1007/s11010-015-2555-3

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  22 in total

Review 1.  The protein kinase complement of the human genome.

Authors:  G Manning; D B Whyte; R Martinez; T Hunter; S Sudarsanam
Journal:  Science       Date:  2002-12-06       Impact factor: 47.728

Review 2.  An overview of the KIN1/PAR-1/MARK kinase family.

Authors:  Jean-Pierre Tassan; Xavier Le Goff
Journal:  Biol Cell       Date:  2004-04       Impact factor: 4.458

3.  Emk, a protein kinase with homologs in yeast maps to mouse chromosome 19.

Authors:  J D Inglis; M Lee; R E Hill
Journal:  Mamm Genome       Date:  1993       Impact factor: 2.957

4.  C-TAK1 protein kinase phosphorylates human Cdc25C on serine 216 and promotes 14-3-3 protein binding.

Authors:  C Y Peng; P R Graves; S Ogg; R S Thoma; M J Byrnes; Z Wu; M T Stephenson; H Piwnica-Worms
Journal:  Cell Growth Differ       Date:  1998-03

5.  Human microtubule affinity-regulating kinase 4 is stable at extremes of pH.

Authors:  Farha Naz; Parvesh Singh; Asimul Islam; Faizan Ahmad; Md Imtaiyaz Hassan
Journal:  J Biomol Struct Dyn       Date:  2015-08-21

6.  Immune system dysfunction and autoimmune disease in mice lacking Emk (Par-1) protein kinase.

Authors:  J B Hurov; T S Stappenbeck; C M Zmasek; L S White; S H Ranganath; J H Russell; A C Chan; K M Murphy; H Piwnica-Worms
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

7.  LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1.

Authors:  Jose M Lizcano; Olga Göransson; Rachel Toth; Maria Deak; Nick A Morrice; Jérôme Boudeau; Simon A Hawley; Lina Udd; Tomi P Mäkelä; D Grahame Hardie; Dario R Alessi
Journal:  EMBO J       Date:  2004-02-19       Impact factor: 11.598

8.  Comprehensive proteomic analysis of human Par protein complexes reveals an interconnected protein network.

Authors:  Miro Brajenovic; Gerard Joberty; Bernhard Küster; Tewis Bouwmeester; Gerard Drewes
Journal:  J Biol Chem       Date:  2003-12-15       Impact factor: 5.157

9.  How to measure and predict the molar absorption coefficient of a protein.

Authors:  C N Pace; F Vajdos; L Fee; G Grimsley; T Gray
Journal:  Protein Sci       Date:  1995-11       Impact factor: 6.725

Review 10.  Structure and regulation of MARK, a kinase involved in abnormal phosphorylation of Tau protein.

Authors:  Thomas Timm; Alexander Marx; Saravanan Panneerselvam; Eckhard Mandelkow; Eva-Maria Mandelkow
Journal:  BMC Neurosci       Date:  2008-12-03       Impact factor: 3.288

View more
  6 in total

Review 1.  Microtubule affinity-regulating kinases are potential druggable targets for Alzheimer's disease.

Authors:  Narendran Annadurai; Khushboo Agrawal; Petr Džubák; Marián Hajdúch; Viswanath Das
Journal:  Cell Mol Life Sci       Date:  2017-06-20       Impact factor: 9.261

Review 2.  Exploring Missense Mutations in Tyrosine Kinases Implicated with Neurodegeneration.

Authors:  Neha Sami; Vijay Kumar; Asimul Islam; Sher Ali; Faizan Ahmad; Imtaiyaz Hassan
Journal:  Mol Neurobiol       Date:  2016-08-20       Impact factor: 5.590

3.  Microtubule affinity-regulating kinase 4 with an Alzheimer's disease-related mutation promotes tau accumulation and exacerbates neurodegeneration.

Authors:  Toshiya Oba; Taro Saito; Akiko Asada; Sawako Shimizu; Koichi M Iijima; Kanae Ando
Journal:  J Biol Chem       Date:  2020-10-05       Impact factor: 5.157

4.  Elucidation of Dietary Polyphenolics as Potential Inhibitor of Microtubule Affinity Regulating Kinase 4: In silico and In vitro Studies.

Authors:  Parvez Khan; Shafikur Rahman; Aarfa Queen; Saaliqa Manzoor; Farha Naz; Gulam Mustafa Hasan; Suaib Luqman; Jihoe Kim; Asimul Islam; Faizan Ahmad; Md Imtaiyaz Hassan
Journal:  Sci Rep       Date:  2017-08-25       Impact factor: 4.379

5.  Probing the Inhibition of Microtubule Affinity Regulating Kinase 4 by N-Substituted Acridones.

Authors:  Maria Voura; Parvez Khan; Savvas Thysiadis; Sotiris Katsamakas; Aarfa Queen; Gulam Mustafa Hasan; Sher Ali; Vasiliki Sarli; Md Imtaiyaz Hassan
Journal:  Sci Rep       Date:  2019-02-08       Impact factor: 4.379

6.  A Network-Guided Approach to Discover Phytochemical-Based Anticancer Therapy: Targeting MARK4 for Hepatocellular Carcinoma.

Authors:  Sarfraz Ahmed; Mohammad Mobashir; Lamya Ahmed Al-Keridis; Nawaf Alshammari; Mohd Adnan; Mohammad Abid; Md Imtaiyaz Hassan
Journal:  Front Oncol       Date:  2022-07-22       Impact factor: 5.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.